| Tag | Content |
|---|
EnhancerAtlas ID | HS139-03243 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr1:151611600-151612710 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| GATA2 | MA0036.3 | chr1:151612531-151612542 | AGAGATAAGAA | - | 6.32 | | Gata1 | MA0035.3 | chr1:151612531-151612542 | AGAGATAAGAA | - | 6.32 | | Gata4 | MA0482.1 | chr1:151612530-151612541 | AAGAGATAAGA | - | 6.02 | | HOXA9 | MA0594.2 | chr1:151611854-151611864 | GTCGTAAACG | + | 6.02 | | MEF2A | MA0052.3 | chr1:151611817-151611829 | TTTATTTTTAGA | - | 6.07 | | MEF2C | MA0497.1 | chr1:151611816-151611831 | TTTTATTTTTAGATA | - | 6.26 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_09648 | chr1:151609713-151613971 | CD14 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I151639 | chr1 | 151611541 | 151611691 |
|
Enhancer Sequence | TGTCAGCCCA ACTCGATCCT CGAACATCTA GCTTTGTTTC CCCTAGTCTT ATAATTATGA 60
AACTATTATA GTGGTAGATA AAAGGCTGCA ACCTAGGTCA GTTTGTCTAC CAGGAGGATG 120
AGTTCACACA TAAATAAAAG ACACTGACCC TGATTTATTG CAGGGGGTGA ATTACAGTAG 180
TGGAAAAGAG TCCTACTCAG CTTGAGTATA ATTCCATTTT ATTTTTAGAT AGTTTCAAGT 240
TTGCATTCTG GTTTGTCGTA AACGTGTGAG TTTTTGTTTA GTTTCTTTTT TGTTTGTTCT 300
TTTGTTGGTT GCCGTATCTC TTTGCTAATA GTATCTTATT TACTGTTGAT TCTGTGGTGC 360
TATAGGGCAA GATTAATGTA AAAGGATGGT GTCCTTCAAG ATATTTGGGT AATAGAGAGG 420
TTCACCCATT TCAGAACTTA GATGTCTCTA CTCTTCTTTC CACATCATGT TCTTTTTCAT 480
TTTCTTTGGA GATATCCGTG TGAATGATTA ACTGTGGTTT TTCCCACGAG TTTCCTGAAT 540
GCAATTCCCA TGAGCTGTTT CACACATTTC TAATCTGTTG CTGTTGTAGC TATGCAGGAA 600
AGCCCATCTT GAATTTTTAG TGATGTGTGC TAGCCCCTTT GCTGAATGCC TTTGTTCTTC 660
AGAGCCTAAT TGCCACTGAT AGCTCAGTCT ACTTAATTTT TCTTTTGGTT GCAATATGCT 720
TTATTTGCCT TTAATTATTT GTGGAGTGTT GATATAATGA GAAATGTTCA TTATTCTTAG 780
TAGAAAATGC AGTGGGTTCT GTTAGATGCT GGCAAACAGA CTACAGGTTT TAAAGCTTAA 840
CAGTTGACTA AAGTTACAGT CTCTAAAACT GAGATTTATC CTCTGCATAG GAACGAGCTA 900
CTAAACATTT ATGGTAAATT CTTTTTAGTG AAGAGATAAG AAAAGCAAGG AAGCTAAAAG 960
AGTTGCAGAG GATCAAATAA TGCTTGGTTG CATCTGTAAT TAGCTGTAGA TAATGGCATA 1020
TAGGTTTTAT TTCAGCATGG ACTTCTGTAG TCTTAGAACC ACACACAGAA TTTAGAGTTT 1080
TATGCTTCCT AAGTGCTAAC TTTGAGTCAT 1110
|
